These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 1309412)

  • 1. Pathologic findings in nonpalpable invasive breast cancer.
    McKinney CD; Frierson HF; Fechner RE; Wilhelm MC; Edge SB
    Am J Surg Pathol; 1992 Jan; 16(1):33-6. PubMed ID: 1309412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment and survival of female patients with nonpalpable breast carcinoma.
    Tinnemans JG; Wobbes T; Holland R; Hendriks JH; Van der Sluis RF; De Boer HH
    Ann Surg; 1989 Feb; 209(2):249-53. PubMed ID: 2537064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonpalpable breast cancer: needle-localized biopsy for diagnosis and considerations for treatment.
    Marrujo G; Jolly PC; Hall MH
    Am J Surg; 1986 May; 151(5):599-602. PubMed ID: 3010754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathological findings of breast cancer in patients surviving 25 years after radical mastectomy.
    Dawson PJ; Ferguson DJ; Karrison T
    Cancer; 1982 Nov; 50(10):2131-8. PubMed ID: 6290024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentricity in nonpalpable breast carcinoma and its implications for treatment.
    Tinnemans JG; Wobbes T; van der Sluis RF; Lubbers EJ; de Boer HH
    Am J Surg; 1986 Mar; 151(3):334-8. PubMed ID: 3006532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammographically detected breast cancer. Nonpalpable is not a synonym for inconsequential.
    Schwartz GF; Carter DL; Conant EF; Gannon FH; Finkel GC; Feig SA
    Cancer; 1994 Mar; 73(6):1660-5. PubMed ID: 8156493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Axillary lymph node dissection in clinically occult breast cancer].
    Le Bouëdec G; Pomel C; Chamussy E; Feillel V; de Latour M; Dauplat J
    Bull Cancer; 1996 Jul; 83(7):581-8. PubMed ID: 8868947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of conservative therapy for invasive breast cancer by histologic subtype.
    Weiss MC; Fowble BL; Solin LJ; Yeh IT; Schultz DJ
    Int J Radiat Oncol Biol Phys; 1992; 23(5):941-7. PubMed ID: 1322387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma?
    Silverstein MJ; Lewinsky BS; Waisman JR; Gierson ED; Colburn WJ; Senofsky GM; Gamagami P
    Cancer; 1994 Mar; 73(6):1673-7. PubMed ID: 8156495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Well-differentiated (tubular) carcinoma of the breast. A clinicopathologic study of 145 pure and mixed cases.
    Deos PH; Norris HJ
    Am J Clin Pathol; 1982 Jul; 78(1):1-7. PubMed ID: 6285690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of occult invasive breast cancer after excisional biopsy showing in-situ ductal carcinoma of comedo pattern.
    Hardman PD; Worth A; Lee U; Baird RM
    Can J Surg; 1989 Jan; 32(1):56-60. PubMed ID: 2535949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sensitivity of pre-operative axillary staging in breast cancer: comparison of invasive lobular and ductal carcinoma.
    Topps A; Clay V; Absar M; Howe M; Lim Y; Johnson R; Bundred N
    Eur J Surg Oncol; 2014 Jul; 40(7):813-7. PubMed ID: 24797703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically occult breast cancer. Multicentricity and implications for treatment.
    Schwartz GF; Patchefsky AS; Feig SA; Shaber GS; Schwartz AB
    Ann Surg; 1980 Jan; 191(1):8-12. PubMed ID: 6243455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive breast carcinoma: frequency of unsuspected invasion and implications for treatment.
    Rosen PP; Senie R; Schottenfeld D; Ashikari R
    Ann Surg; 1979 Mar; 189(3):377-82. PubMed ID: 218506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Accuracy of conservative treatment for infiltrating lobular breast cancer: a retrospective study of 217 infiltrating lobular carcinomas and 2155 infiltrating ductal carcinomas].
    Paumier A; Sagan C; Campion L; Fiche M; Andrieux N; Dravet F; Pioud R; Classe JM
    J Gynecol Obstet Biol Reprod (Paris); 2003 Oct; 32(6):529-34. PubMed ID: 14593298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of sentinel lymph node biopsy between invasive lobular carcinoma and invasive ductal carcinoma.
    Adachi Y; Sawaki M; Hattori M; Yoshimura A; Gondo N; Kotani H; Iwase M; Kataoka A; Onishi S; Sugino K; Terada M; Horisawa N; Mori M; Oze I; Iwata H
    Breast Cancer; 2018 Sep; 25(5):560-565. PubMed ID: 29536376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive pure ductal carcinoma in situ of the breast: identification of predictors of associated infiltrating carcinoma and lymph node metastasis before immediate reconstructive surgery.
    Guillot E; Vaysse C; Goetgeluck J; Falcou MC; Couturaud B; Fitoussi A; Fourchotte V; Laki F; Malhaire C; Sigal-Zafrani B; Sastre-Garau X; Bollet MA; Mosseri V; Reyal F
    Breast; 2014 Apr; 23(2):97-103. PubMed ID: 24388733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sentinel lymph node metastasis in patients with ductal breast carcinoma in situ].
    Ruvalcaba-Limón E; de Jesús Garduño-Raya M; Bautista-Piña V; Trejo-Martínez C; Maffuz-Aziz A; Rodríguez-Cuevas S
    Cir Cir; 2014; 82(2):129-41. PubMed ID: 25312311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes.
    Veronesi U; Cascinelli N; Greco M; Bufalino R; Morabito A; Galluzzo D; Conti R; De Lellis R; Delle Donne V; Piotti P
    Ann Surg; 1985 Dec; 202(6):702-7. PubMed ID: 3000303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-excision rates of invasive ductal carcinoma with lobular features compared with invasive ductal carcinomas and invasive lobular carcinomas of the breast.
    Arps DP; Jorns JM; Zhao L; Bensenhaver J; Kleer CG; Pang JC
    Ann Surg Oncol; 2014 Dec; 21(13):4152-8. PubMed ID: 24980090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.